Vision Statement

Therapeutic drug monitoring and analysis+consulting for clinical toxicology are forms of personalized medicine “avant la lettre”. IATDMCT has promoted the individualization of treatment before the term personalized medicine had even been invented. Our strength is the analytical expertise and translation of laboratory results into practical treatment recommendations . My mission will be to promote the added value of our contribution, to increase the visibility of IATDMCT and to increase involvement of clinicians into our Association.

 

  • 2010- Professor in Clinical Pharmacology
    Internist-clinical pharmacologist, Dept Hospital Pharmacy, Erasmus Medical Center – Rotterdam – NL
    Internist-nephrologist, Dept Internal Medicine, Erasmus Medical Center – Rotterdam – Netherlands
  • 2002-2010 Internist-clinical pharmacologist, Dept Hospital Pharmacy
    Internist-nephrologist, Dept Internal Medicine
    Both at Erasmus Medical Center – Rotterdam – The Netherlands
  • 2000-2002 Head of the Renal Transplantation Unit – Dept Internal Medicine – Erasmus Medical Center
  • 1998-1999 Post-doctoral fellow Dept Cardiothoracic Surgery –
    Laboratory for Transplantation Immunology, Stanford University – Palo Alto – USA
  • 1996-1998 Internist-nephrologist, Erasmus Medical Center – Rotterdam – The Netherlands
  • 1993-1996 Internist, Erasmus Medical Center – Rotterdam – The Netherlands
  • 1988-1993 Resident Internal Medicine, Erasmus Medical Center – Rotterdam – The Netherlands
  • 1987-1988 MD in (mandatory) Military Service
  • Clinical Pharmacology (certification: December 1, 2003)
    Trained at University Medical Center Nijmegen – Netherlands in 2002-2003
  • Post-doctoral fellowship (Transplantation Immunology)
    Stanford University 1998-1999 (Professor Randall E Morris)
  • Thesis (Erasmus University Rotterdam) date : May 15, 1996 PhD. Title of thesis “The role of anti Interleukin-2 receptor monoclonal antibody (BT563) in the prevention of acute rejection after organ transplantation”
  • Nephrology (certification April 16, 1996)
    Trained at University Hospital Rotterdam 1995-1996
  • Internal Medicine (certification May 1, 1993)
    Trained at University Hospital Rotterdam 1988-1993
  • Medicine (certification as MD at Feb 20, 1987)
    Trained at Erasmus University Rotterdam 1980-1987 MD
  • Since 2003 member of IATDMCT.
  • From 2005-2009 Councilor of IATDMCT
  • From 2009-2013 Director of Education within Council of IATDMCT
  • From 2009-2013 Chair of Immunosuppressive drugs committee of IATDMCT
  • From 2009 – 2015 Secretary of Dutch Transplantation Society
  • Since 2011 Chairman of Dutch Society for Clinical Pharmacology and Biopharmacy

Web-of-Science: 346 publications, H-index 39, with 6079 citations (as of March 2015)
Speaker at numerous conferences, both national and international.

  • 1994 Nephrology Award (Dutch Society for Nephrology)
  • 1996 Jon J. van Rood Award (Dutch Transplantation Society)
  • 1997 Young Investigator Award (European Society Heart Lung Transplantation)
  • 1998 International Young Investigator Award (American Society Transplant Physicians)
  • 2000 International Young Investigator Award (American Society of Transplantation)
  • 2005 Outstanding Speaker Award (American Association for Clinical Chemistry)
  • 2009 Visiting Professor Nephrology West China Medical School Chengdu (China)
  • 2010 Visiting Professor (Kathleen Valles Chair) St George’s Medical School London (UK)
  • 2011 Teacher of the year award (medical students – Erasmus University Rotterdam)